Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa
Joint Authors
Vieira Maciel, Maria Amélia
Cavalcanti, Isabella Macário Ferro
Costa-Junior, Sérgio Dias
da Silva, Wagner Roberto Cirilo
da Silva, Adriana Maria Costa Marques
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-08-12
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
The present study aimed to characterize the susceptibility profile of Pseudomonas aeruginosa and Acinetobacter spp.
clinical isolates to polymyxin B in a public hospital in Recife-PE, Brazil, between the years of 2018 and 2019, as well as to search for the presence of the mcr-1 gene and evaluate the interaction between polymyxin B and usnic acid against these isolates.
The strains were identified using the BD Phoenix™ automated system and the agar-spot test was used to determine the susceptibility profile to polymyxin B.
The minimum inhibitory concentrations (MICs) of usnic acid and polymyxin B were determined through the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI).
Subsequently, Polymerase Chain Reaction (PCR) was performed to detect the mcr-1 gene in the isolates.
The interaction between usnic acid and polymyxin B was evaluated by the Checkerboard assay.
Among 34 isolates of P.
aeruginosa, 26.5% (9/34) were positive for the polymyxin B agar-spot test, and 11.8% (4/34) presented an intermediate susceptibility (MIC = 4 μg/mL), while 14.7% (5/34) presented antimicrobial resistance with MIC values ranging from 8 to 32 μg/mL.
Among 38 isolates of Acinetobacter spp., 13.2% (5/38) were positive for the polymyxin B agar-spot test and all of them were resistant to polymyxin B with a MIC value > 32 μg/mL.
The mcr-1 gene was not detected in the clinical isolates.
Regarding usnic acid, it presented a moderate antibacterial activity against two P.
aeruginosa isolates (MIC = 250 μg/mL) and no activity was detected against the others.
A synergistic effect between usnic acid and polymyxin B was observed against three clinical isolates of P.
aeruginosa which were resistant to polymyxin B (FICI ≤ 0.5).
Therefore, it was possible to observe that usnic acid is a promising candidate to be used in combination with polymyxin B against infections caused by resistant P.
aeruginosa.
American Psychological Association (APA)
Costa-Junior, Sérgio Dias& da Silva, Wagner Roberto Cirilo& da Silva, Adriana Maria Costa Marques& Vieira Maciel, Maria Amélia& Cavalcanti, Isabella Macário Ferro. 2020. Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa. Evidence-Based Complementary and Alternative Medicine،Vol. 2020, no. 2020, pp.1-9.
https://search.emarefa.net/detail/BIM-1158775
Modern Language Association (MLA)
Costa-Junior, Sérgio Dias…[et al.]. Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa. Evidence-Based Complementary and Alternative Medicine No. 2020 (2020), pp.1-9.
https://search.emarefa.net/detail/BIM-1158775
American Medical Association (AMA)
Costa-Junior, Sérgio Dias& da Silva, Wagner Roberto Cirilo& da Silva, Adriana Maria Costa Marques& Vieira Maciel, Maria Amélia& Cavalcanti, Isabella Macário Ferro. Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa. Evidence-Based Complementary and Alternative Medicine. 2020. Vol. 2020, no. 2020, pp.1-9.
https://search.emarefa.net/detail/BIM-1158775
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1158775